Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Timolol 0.5% vs IPL for Post-Inflammatory Erythema in Acne Vulgaris
NCT07474883Phase 1Recruiting
- Sponsor
- Pham Ngoc Thach University of Medicine
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of timolol maleate gel + placebo in Postinflammatory erythema (PIE) (2 arms), sponsored by Pham Ngoc Thach University of Medicine. Primary endpoints: Clinician Erythema Assessment at Day 28 and Number of Post Inflammatory Erythema lesions at Day 28. Started Mar 2026; status: recruiting.
02
Drugs
timolol maleate gel + placebo
03
Conditions
Postinflammatory erythema (PIE)
Beyond the preview
Go deeper on NCT07474883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07474883.